RMD Logo

ResMed Inc. (RMD) 

NYSE
Market Cap
$35.65B
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
381 of 774
Rank in Industry
27 of 48

Largest Insider Buys in Sector

RMD Stock Price History Chart

RMD Stock Performance

About ResMed Inc.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software …

Insider Activity of ResMed Inc.

Over the last 12 months, insiders at ResMed Inc. have bought $0 and sold $46.44M worth of ResMed Inc. stock.

On average, over the past 5 years, insiders at ResMed Inc. have bought $0 and sold $37.16M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 10,000 shares for transaction amount of $424,500 was made by SULPIZIO RICHARD (director) on 2006‑08‑21.

List of Insider Buy and Sell Transactions, ResMed Inc.

2024-11-12Saledirector
796
0.0005%
$248.81$198,053-4.76%
2024-11-08SaleChief Financial Officer
1,000
0.0007%
$249.00$249,000-4.29%
2024-11-07SaleChief Executive Officer
14,683
0.0099%
$246.26$3.62M-1.67%
2024-11-06Saledirector
2,000
0.0014%
$248.74$497,480+0.86%
2024-11-01SaleGlobal General Counsel
69
<0.0001%
$242.00$16,698+0.34%
2024-10-11SaleChief Commercial Officer, SaaS
4,260
0.0029%
$238.48$1.02M+0.81%
2024-10-08SaleChief Financial Officer
1,000
0.0007%
$233.47$233,470+2.15%
2024-10-07SaleChief Executive Officer
14,683
0.0096%
$231.91$3.41M+3.62%
2024-10-02Saledirector
2,000
0.0013%
$237.20$474,400+0.59%
2024-09-12SaleChief Commercial Officer, SaaS
5,000
0.0034%
$252.56$1.26M-3.99%
2024-09-09SaleChief Executive Officer
14,683
0.0099%
$248.38$3.65M-3.21%
2024-09-09SaleChief Financial Officer
1,000
0.0007%
$246.42$246,420-3.21%
2024-09-04Saledirector
2,000
0.0013%
$239.90$479,800-0.83%
2024-08-20SaleGlobal General Counsel
882
0.0006%
$231.00$203,742+8.71%
2024-08-12SalePresident, SaaS Business
10,000
0.0069%
$216.60$2.17M+13.18%
2024-08-08SaleChief Financial Officer
1,000
0.0007%
$212.16$212,160+12.94%
2024-08-07SaleChief Executive Officer
14,683
0.0102%
$214.25$3.15M+14.51%
2024-08-05SalePresident, Asia Latin America
48,000
0.0329%
$217.07$10.42M+11.61%
2024-07-08SaleChief Executive Officer
14,683
0.0103%
$192.97$2.83M0.00%
2024-07-08SaleChief Financial Officer
1,000
0.0007%
$194.35$194,3500.00%

Insider Historical Profitability

6.07%
SULPIZIO RICHARDdirector
26527
0.0181%
$242.8811+6.07%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$3.52B12.117.77M+0.15%+$5.21M0.07
BlackRock$2.41B8.312.19M-0.44%-$10.62M0.05
State Street$1.25B4.296.3M+0.14%+$1.77M0.05
BNY Mellon$755.11M2.63.81M+230.31%+$526.5M0.14
Geode Capital Management$676.12M2.333.42M-0.35%-$2.39M0.06
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.